Normotest and abnormal prothrombin in liver transplantation.
Postoperative changes in coagulation parameters, including the abnormal plasma prothrombin level, were studied in 95 patients who underwent liver transplantation, and the results were compared with the clinical outcome. The patients were classified into four groups: Group I had a satisfactory postoperative course, (n = 76), Group II suffered graft failure or death at 31 days or more after transplantation (n = 9); Group III suffered graft failure or death from 8 to 30 days after transplantation (n = 4); and Group IV suffered graft failure or death within 7 days of transplantation (n = 6). The Normotest, which closely reflected liver graft function, showed an increase immediately after transplantation in Group I, II, and III, but showed a marked decrease in Group IV. In patients with severe acute cellular rejection, the plasma level of abnormal prothrombin (des-gamma-carboxy prothrombin) was compared with the histology of the liver biopsy specimen. When liver graft function was good after orthotopic transplantation, the Normotest value recovered to the normal range of 70% or more. Subsequently, graft function remained good when the des-gamma-carboxy prothrombin level stayed low, whereas acute cellular rejection was indicated by an elevation of des-gamma-carboxy prothrombin was not produced by graft with early failure, the des-gamma-carboxy prothrombin level also remained low. Thus, the Normotest value and the des-gamma-carboxy prothrombin level were both useful parameters for assessing hepatic function and rejection after transplantation.
Department of Surgery, University of Pittsburgh School of Medicine, PA, USA.
A
A
Nakao
Y
Y
Iwaki
M A
MA
Virji
Y
Y
Kita
A J
AJ
Demetris
S
S
Iwatsuki
T E
TE
Starzl
D000328:Adult; D015415:Biomarkers; D001779:Blood Coagulation Factors / Q000032:analysis*; D005260:Female; D006801:Humans; D008107:Liver Diseases / Q000097:blood / Q000601:surgery*; D016031:Liver Transplantation; D008297:Male; D008875:Middle Aged; D010314:Partial Thromboplastin Time; D011184:Postoperative Period; D011498:Protein Precursors / Q000032:analysis*; D011516:Prothrombin / Q000032:analysis*; D011517:Prothrombin Time; D016896:Treatment Outcome
D015415:Biomarkers; D001779:Blood Coagulation Factors; D011498:Protein Precursors; C008208:acarboxyprothrombin; D011516:Prothrombin